A new study by Transparency Market Research (TMR), titled “Pruritus Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2015 - 2023,” states that the rising prevalence of allergic contact dermatitis, atopic dermatitis, and urticaria is boosting the worldwide market for pruritus therapeutics.
In addition to this, the presence of a robust portfolio of pipeline products for the treatment of pruritus is likely to propel this market during the forecast period. However, the dearth of therapies based on mechanistic understanding is anticipated to restrict this market from registering steady growth in the coming years, reports the research study.
The report has evaluated the global pruritus therapeutics market on the basis of the type of disease, drug class, and the geographical distribution of this market. Based on the type of disease, the market has been segmented into allergic contact dermatitis, atopic dermatitis, urticaria, and various other types of skin allergies. Among these, allergic contact dermatitis is the most prevalent disease across the world, owing to which the demand for pruritus therapeutics is the highest from this segment. The segment is projected to witness steady demand in the coming years, thereby maintaining its lead in the market during the forecast period.
Based on the drug class, the market has been classified into antihistamines (loratadine and doxepin), opioid receptor antagonists (naltrexone and naloxone), topical corticosteroids (clobetasol propionate), topical immunomodulators (calcineurin inhibitors such as pimecrolimus and tacrolimus), immunosuppressants (azathioprine and cyclosporine), neuroleptics (pregabalin and gabapentin), antidepressants (SNRI and mirtazapine), cannabinoid receptors (N-palmitoylethanolamine and CB2 agonist), topical local anesthetics (pramoxine), and other drugs (antipruritics such as camphor, salicylic acid, capsaicin, polidocanol, and menthol).
Among these, the topical corticosteroids segment has been leading the overall market since the last few years. The segment is projected to record a significant growth rate during the forecast period, states the research report.
Download Exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8815
On the regional basis, the global market for pruritus therapeutics has been segmented into North America, Asia Pacific, Europe, and the Rest of the World in this report. North America has been dominating the overall market since the last few years on account of the increased prevalence of target diseases. However, Asia Pacific is anticipated to register the fastest growth over the forecast period due to the prevalence of unmet healthcare needs.
Novartis AG, Allergan Inc., Astellas Pharma Inc., Amgen Inc., CARA Therapeutics, and Teva Pharmaceutical Industries Ltd. are the leading players in the global market for pruritus therapeutics. Other prominent companies operating in this market are NeRRe Therapeutics, Ocera Therapeutics Inc., Trevi Therapeutics, Actavis, Tai Guk Pharmaceutical Co., Pfizer, and Sanofi.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.